Grifols SA (GRFS)
8.58
-0.01
(-0.12%)
USD |
NASDAQ |
Mar 06, 12:01
Grifols Market Cap : 5.839B for March 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 0.7946M |
| Akari Therapeutics Plc | 11.68M |
| Pharma Mar SA | 1.537B |
| Oryzon Genomics SA | 256.27M |
| Evaxion AS | 26.27M |
Market Cap Related Metrics
| PE Ratio | 12.73 |
| PS Ratio | 0.6857 |
| PEG Ratio | 0.0748 |
| Price to Book Value | 2.486 |
| Price to Free Cash Flow | 8.254 |
| Price | 8.58 |
| Earnings Yield | 7.85% |
| PEGY Ratio | 0.0739 |
| Operating PE Ratio | 4.123 |
| Normalized PE Ratio | 13.33 |